Professional Documents
Culture Documents
75.0 mg PPH, 150.0 mg DEX and 50.0 mg CET were transferred to a 50.0 mL volumetric flask and diluted upto
mark with mobile phase. (Conc. 1500g/mL of PPH , 3000g/mL of DEX and 1000g/mL of CET)
A 5.0 mL of solution PC1 was diluted to 50.0 mL in a volumetric flask with mobile phase. (Conc. 150g/mL of
PPH, 300g/mL of DEX and 100g/mL of CET)
Accurately weighed quantities about 460 mg of Ammonium Sulphate and 1000 mg of Octane 1-sulphonic acid
sodium salt were dissolved in 1000.0 mL of double distill water and pH was adjusted to 3.4 with 10% glacial
acetic acid.
HPLC method was developed on a Xterra C18 (250 x 4.6 mm, 5) stationary phase with a mobile phase consisting of
Acetonitrile:Methenol:Ammonium sulphate buffer (30:15:55) having P H 3.4, effluent flow rate (1.0 mL/min) and detected
at multiwavelength i.e. 272, 230 the column was maintain at temperature 2830 oC.
PROCEDURE :
Preparation of stress sample solutions
Accurately weighed quantities of 5.0 mL of syrup equivalent to 7.5 mg of PPH (15.0 mg DEX, 5.0 mg CET) were
transferred to series of 50.0 mL volumetric flasks. To each flask 5.0 mL of reagent (0.1N HCl/0.1N NaOH/ 3%
H2O2) was added and kept at RT for a period of 24 h. After 24 h, the content of each flask was diluted with mobile
phase, sonicated for 15 min and samples were filtered separately. The recorded chromatograms of blank (Fig A)
and sample after 24 h are depicted in Fig B-D in acidic, alkaline and peroxide stress respectivel
RESULTSAND DISSCUTION :
The stability of the drugs was carried out for solution state stability and solid state stability .The results of solution state
analysis indicate that in sample PPH, DEX and CET were degraded to about 4.55%, 8.08% and 4.67% in acid, 4.44%, 6.88%
and 4.07% in alkali, 2.34%, 6.37% and 2.66% in peroxide when compared to unexposed sample. The results of solid state
stability after 48 h indicate that in sample PPH, DEX and CET were degraded to 1.83%, 3.88% and 3.63% when exposed to
humidity, 1.7%, 4.28% and 2.83% when exposed to thermal, 3.99%, 6.43% and 3.45% when exposed to UV radiation as
compared to unexposed sample.
Observations and results of estimation
Agrus-NS
Wt. of
AUC (V)
Std.
syrup
(mL)
5.0
PPH
2357018
DEX
8702983
Sample
CET
5880978
% of Labeled claim
PPH
DEX
CET
PPH
DEX
CET
PPH
DEX
CET
2369752
2358341
2364760
8599511
8670524
8689577
5949972
5910544
5978647
7.53
7.49
7.51
14.93
15.05
15.09
5.00
4.97
5.02
99.30
100.12
100.34
99.60
98.94
100.08
2377597
8582191
5936232
7.55
14.90
4.99
99.68
99.20
99.47
100.0
99.10
99.37
2388058
8587387
5951167
7.58
14.91
5.00
99.16
99.62
2356439
8590850
5926674
7.48
14.91
4.98
Mean
99.20
99.53
0.54
99.21
99.47
0.39
0.55
0.39
SD
%RSD
1
100.4
5
99.12
99.65
0.50
0.51
Summary of estimation
Combined
PPH
dosage form
Mean*
99.65
SD
0.50
%RSD
0.51
*Mean of five/six observations
M5
DEX
99.53
0.54
0.55
CET
99.47
0.39
0.39
Her Majesty Stationary Office Landon Medicine and Healthcare Products Regulatory Agency, London, (1994)
British Pharmacopoeia, Vol. II: 1300.
Rajan, Sekar, Colaco, Socorrina, Ramesh, N, Meyyanathan, Subramania N, Elango, K. (2014) Development and
validation of dissolution study of sustained release dextromethorphan hydrobromide tablets. Pakistan Journal of
chlorpheniramine
maleate
and
dextromethorphan
hydrobromide
in
pharmaceutical